Objective: To assess whether the implementation of an intensive care unit (ICU) rounding checklist reduces the number of catheter-associated urinary tract infections (CAUTIs).
Design: Retrospective before-and-after study that took place between March 2013 and February 2017.
Setting: An academic community hospital 16-bed, mixed surgical, cardiac, medical ICU.
Patients: Participants were all patients admitted to the adult mixed ICU and had a diagnosis of CAUTI.
Intervention: Initiation of an ICU rounding checklist that prompts physicians to address any use of urinary catheters with analysis comparing the preintervention period before roll out of the rounding checklist versus the postintervention periods.
Results: There were 19 CAUTIs and 9,288 urinary catheter days (2.04 CAUTIs per 1,000 catheter days). The catheter utilization ratio increased in the first year after the intervention (0.67 vs 0.60; P = .0079), then decreased in the second year after the intervention (0.53 vs 0.60; P = .0992) and in the third year after the intervention (0.53 vs 0.60; P = .0224). The rate of CAUTI (ie, CAUTI per 1,000 urinary catheter days) decreased from 4.62 before the checklist was implemented to 2.12 in the first year after the intervention (P = .2104). The CAUTI rate was 0.45 in the second year (P = .0275) and 0.96 in the third year (P = .0532).
Conclusions: Our study suggests that utilization of a daily rounding checklist is associated with a decrease in the rates of CAUTI in ICU patients. Incorporating a rounding checklist is feasible in the ICU.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1017/ice.2020.43 | DOI Listing |
Lancet Digit Health
December 2024
University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Birmingham, UK; Centre for Patient Reported Outcomes Research, School of Health Sciences, College of Medical and Dental Sciences, Birmingham, UK; University of Birmingham, Birmingham, UK. Electronic address:
Without careful dissection of the ways in which biases can be encoded into artificial intelligence (AI) health technologies, there is a risk of perpetuating existing health inequalities at scale. One major source of bias is the data that underpins such technologies. The STANDING Together recommendations aim to encourage transparency regarding limitations of health datasets and proactive evaluation of their effect across population groups.
View Article and Find Full Text PDFZhongguo Zhong Yao Za Zhi
October 2024
Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
This study aims to establish the implementation standard of health technology assessment(HTA) in traditional Chinese medicine(TCM), so as to promote the scientific and standardized implementation and application of HTA in TCM for high-quality decision-making. Based on the published HTA method guidelines, the literature analysis and expert consensus method were used to establish the implementation standard of HTA in TCM with implementation steps, assessment domains, and reporting checklists as the main content. A total of 41 HTA guidelines were included.
View Article and Find Full Text PDFRev Gaucha Enferm
December 2024
Universidade Federal de Minas Gerais, Escola de Enfermagem, Departamento de Enfermagem Materno Infantil, Belo Horizonte, Minas Gerais, Brasil.
Objective: To develop and validate the content of checklists for safe admission and discharge in Neonatal Intensive Care Units.
Methods: A methodological study conducted between 2018 and 2020 in four stages: 1) literature review; 2) checklist construction; 3) content validity by 32 neonatal nursing specialists from different Brazilian states, predominantly from the southeastern region; 4) development of the final version of the instruments. Validity was performed using a Likert-type scale.
Pediatr Rheumatol Online J
December 2024
Department of Pediatric Rheumatology, University of Health Sciences, Ümraniye Research and Training Hospital, Istanbul, Turkey.
Introduction: Multiple myeloma (MM) is a relapsing, debilitating blood cancer which remains incurable despite advances in treatments. Patients typically receive multiple lines of treatment, to which they become refractory, thereby limiting treatment options. B-cell maturation antigen (BCMA) bispecific antibodies (BsAbs) represent a novel modality of treatment that has significant efficacy for relapsed or refractory patients.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!